Summary
Neuropeptide Y in the hypothalamus is a potent physiological stimulator of feeding, and may contribute to the characteristic metabolic defects of obesity when hypothalamic levels remain chronically elevated. Since corticosterone and insulin are important regulators of fuel metabolism, the longitudinal effects of chronic (6 days) intracerebroventricular infusion of neuropeptide Y in normal rats on the hypothalamo-pituitary-adrenal axis and on insulin secretion were studied. Neuropeptide Y-infused rats were either allowed to eat ad libitum, or were pair-fed with normophagic control rats. Neuropeptide Y increased the basal plasma concentrations of adrenocorticotropic hormone and corticosterone during the first 2 days of its intracerebroventricular infusion and increased cold stress-induced plasma adrenocorticotropic hormone concentrations. After 4-6 days of central neuropeptide Y infusion, however, basal plasma adrenocorticotropic hormone and corticosterone concentrations were no different from control values (except in ad libitum-fed rats in which corticosteronaemia remained elevated), they were unaffected by the stress of cold exposure, and the hypothalamic content of corticotropin-releasing factor immunoreactivity was significantly decreased. A state of hyperinsulinaemia was present throughout the 6 days of intracerebroventricular neuropeptide Y infusion, being more marked in the ad libitum-fed than in the pair-fed group. The proportions of insulin, proinsulin, and conversion intermediates in plasma and pancreas were unchanged. Hyperinsulinaemia of the pair-fed neuropeptide Y-infused rats was accompanied by muscle insulin resistance and white adipose tissue insulin hyperresponsiveness, as assessed by the in vivo uptake of 2-deoxyglucose. Finally, bilateral subdiaphragmatic vagotomy prevented both the basal and the marked glucose-induced hyperinsulinaemia of animals chronically infused with neuropeptide Y, demonstrating that central neuropeptide Y-induced hyperinsulinaemia is mediated by the parasympathetic nervous system.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- NPY:
-
Neuropeptide Y
- i. c. v.:
-
intracerebroven-tricular
- HPA:
-
hypothalamo-pituitary-adrenal
- ACTH:
-
adrenocorticotropic hormone
- CRF:
-
corticotropin-releasing factor
- HPLC:
-
high performance liquid chromatography
- TFA:
-
trifluoroaceti acid
- BSA:
-
bovine serum albumin
- PVN:
-
paraven-tricular nucleus
References
Hendry SHC (1993) Organization of neuropeptide Y neurons in the mammalian central nervous system. In: Colmers WF, Wahlestedt C (eds) The biology of neuropeptide Y and related peptides. Humana Press Inc, New Jersey, pp 65–156
Ergene E, Dunbar JC, Barraco RA (1993) Visceroendocrine responses elicited by neuropeptide Y in the nucleus tractus solitarius. Brain Res Bull 32: 461–465
McDonald JK, Koenig JI (1993) Neuropeptide Y actions on reproductive and endocrine functions. In: Colmers WF, Wahlestadt C (eds) The biology of neuropeptide Y and related peptides. Humana Press Inc, New Jersey, pp 419–456
Stanley BG (1993) Neuropeptide Y in multiple hypothalamic sites controls eating behavior, endocrine, and autonomic systems for body energy balance. In: Colmers WF, Wahlestedt C (eds) The biology of neuropeptide Y and related peptides. Humana Press Inc, New Jersey, pp 457–509
Dryden S, Frankish H, Wang Q, Williams G (1994) Neuropeptide Y and energy balance: one way ahead for the treatment of obesity? Eur J Clin Invest 24: 293–308
Bchini-Hooft van Huijsduijnen O, Rohner-Jeanrenaud F, Jeanrenaud B (1993) Hypothalamic neuropeptide Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa) rats; potential regulation thereof by corticotropin-releasing factor. J Neuroendocrinol 5: 381–386
Williams G, Shellard L, Lewis DE et al. (1992) Hypothalamic neuropeptide Y disturbances in the obese (cp/cp) JCR: LA corpulent rat. Peptides 13: 537–540
Stephens TW, Basinski M, Bristow PK et al. (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377: 530–532
Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF (1986) Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7: 1189–1192
Billington CJ, Briggs JE, Harker S, Grace M, Levine AS (1994) Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol 266: R1765-R1770
Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B (1993) Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133: 1753–1758
Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B (1994) Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 43: 764–769
Vettor R, Zarjevski N, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B (1994) Induction and reversibility of an obesity syndrome by intracerebroventricular neuropeptide Y administration to normal rats. Diabetologia 37: 1202–1208
Sainsbury A, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B (1997) Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats. Diabetes 46: 209–214
Guillaume-Gentil C, Assimacopoulos-Jeannet F, Jeanrenaud B (1993) Involvement of non-esterified fatty acid oxidation in glucocorticoid-induced peripheral insulin resistance in vivo in rats. Diabetologia 36: 899–906
Cusin I, Terrettaz J, Rohner-Jeanrenaud F, Zarjevski N, Assimacopoulos-Jeannet F, Jeanrenaud B (1990) Hyperinsu-linemia increases the amount of GLUT4 mRNA in white adipose tissue and decreases that of muscles: a clue for increased fat depot and insulin resistance. Endocrinology 127: 3246–3248
Coleman DL (1988) Classical diabetes models: past lessions and potential new therapies. In: Shafrir E, Renold AE (eds) Frontiers in diabetes research. Lessons from animal diabetes II. John Libbey & Co Ltd, London, pp 253–256
Nosadini R, Del Prato S, Tiengo A et al. (1983) Insulin resistance in Cushing’s syndrome. J Clin Endocrinol Metab 57: 529–536
Guillaume-Gentil C, Rohner-Jeanrenaud F, Abramo F, Bestetti GE, Rossi GL, Jeanrenaud B (1990) Abnormal regulation of the hypothalamo-pituitary-adrenal axis in the genetically obese fa/fa rat. Endocrinology 126: 1873–1879
Jeanrenaud B (1991) Neuroendocrinology and evolutionary aspects of experimental obesity. In: Oomura Y, Tarui S, Inoue S, Shimazu T (eds) Progress in obesity research 1990. John Libbey, Cornwall, pp 409–421
Sainsbury A, Rohner-Jeanrenaud F, Grouzmann E, Jeanrenaud B (1996) Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats. Neuroendocrinology 63: 318–326
Rohner-Jeanrenaud F, Walker CD, Greco-Perotto R, Jeanrenaud B (1989) Central corticotropin-releasing factor administration prevents the excessive body weight gain of genetically obese (fa/fa) rats. Endocrinology 124: 733–739
Hadid R, Spinedi E, Daneva T, Grau G, Gaillard RC (1995) Repeated endotoxin treatment decreases immune and hypothalamo-pituitary-adrenal axis responses: effects of orchidectomy and testosterone therapy. Neuroendocrinology 62: 348–355
Spinedi E, Giacomini M, Jacquier MC, Gaillard RC (1991) Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action. Neuroendocrinology 53: 160–170
Schnetzler B, Murakawa G, Abalos D, Halban P, Seiden R (1993) Adapatation to supraphysiologic levels of insulin gene expression in transgenic mice: evidence for the importance of posttranscriptional regulation. J Clin Invest 92: 272–280
Sizonenko S, Halban PA(1991) Differential rates of conversion of rat proinsulin I and II: evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II. Biochem J 278: 621–625
Halban PA(1991) Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic beta cell. Diabetologia 34: 767–778
Woods SC, Porte D Jr (1974) Neural control of the endocrine pancreas. Physiol Rev 54: 596–619
Suda T, Tozawa F, Iwai I et al. (1993) Neuropeptide-Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Mol Brain Res 18: 311–315
Haas DA, George SR (1987) Neuropeptide Y administration acutely increases hypothalamic corticotropin-releasing factor immunoreactivity: lack of effect in other rat brain regions. Life Sci 41: 2725–2731
Brooks AN, Howe DC, Porter DWF, Naylor AM (1994) Neuropeptide-Y stimulates pituitary-adrenal activity in fetal and adult sheep. J Neuroendocrinol 6: 161–166
Liu JP, Clarke IJ, Funder JW, Engler D (1994) Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing’s syndrome of endogenous depression and anorexia nervosa. J Clin Invest 93: 1439–1450
Dallman MF, Strack AM, Akana SF et al. (1993) Feast and famine: critical role of glucocorticoids with insulin in daily energy flow. Front Neuroendocrinol 14: 303–347
Miura M, Inui A, Teranishi A et al. (1992) Structural requirements for the effects of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog. Neuropeptides 23: 15–18
Gerald C, Walker MW, Criscione L et al. (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382: 168–171
Brück K (1983) Functions of the endocrine system. In: Schmidt RF, Thews G (eds) Human Physiology. Springer-Verlag, Heidelberg, pp 658–687
Dallman MF, Akana SF, Scribner KA et al. (1992) Mortyn Jones memorial lecture. Stress, feedback and facilitation in the hypothalamo-pituitary adrenal axis. J Neuroendocrinol 4: 517–526
Kaiyala KJ, Woods SC, Schwartz MW (1995) New model for the regulation of energy balance and adiposity by the central nervous system. Am J Clin Nutr 62: 1123S-1134S
Yudkin JS (1993) Circulating proinsulin-like molecules. J Diabetic Complications 7: 113–123
Rhodes CJ, Alarcon C (1994) What beta-cell defect could lead to hyperproinsulinemia in NIDDM — some clues from recent advances made in understanding the proinsulin-processing mechanism. Diabetes 43: 511–517
Porte D Jr (1991) Banting lecture 1990. Beta cells in type II diabetes. Diabetes 40: 166–180
Yoneda M, Tamasawa N, Takebe K et al. (1995) Central neuropeptide Y enhances bile secretion through vagal and muscarinic but not nitric oxide pathways in rats. Peptides 16: 727–732
Stubbs M, York DA (1991) Central glucocorticoid regulation of parasympathetic drive to pancreatic B-cells in the obese fa/fa rat. Int J Obesity 15: 547–553
Fletcher JM, McKenzie N (1988) The parasympathetic nervous system and glucocorticoid-mediated hyperinsulinaemia in the genetically obese (fa/fa) Zucker rat. J Endocrinol 118: 87–92
Siaud P, Puech R, Assenmacher I, Alonso G (1990) Adrenergic innervation of the dorsal vagal motor nucleus: possible involvement in inhibitory control of gastric acid and pancreatic insulin secretion. Cell Tissue Res 259: 535–542
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sainsbury, A., Rohner-Jeanrenaud, F., Cusin, I. et al. Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia 40, 1269–1277 (1997). https://doi.org/10.1007/s001250050820
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s001250050820